Rezolute (RZLT) Accumulated Depreciation (2018 - 2025)
Rezolute (RZLT) posted Accumulated Depreciation of $138000.0 for Q2 2025, up 28.97% sequentially from $107000.0 in Q2 2024, and up 28.97% YoY from $107000.0 in Q2 2024.
Analysis
Rezolute (RZLT) Accumulated Depreciation (2018 - 2025) Analysis & Trends
Rezolute has reported Accumulated Depreciation for 8 years, with the latest figure at $138000.0 in Q2 2025.
- Quarterly Accumulated Depreciation rose 28.97% year-over-year to $138000.0 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $138000.0 (up 28.97% YoY) and the FY2025 annual result came in at $138000.0, up 28.97% from the prior year.
- Accumulated Depreciation improved to $138000.0 in Q2 2025 per RZLT's latest filing, from $107000.0 in the prior quarter.
- Over five years, Accumulated Depreciation peaked at $138000.0 in Q2 2025 and troughed at $27000.0 in Q2 2021.
- A 5-year average of $76600.0 and a median of $71000.0 in 2023 frame the typical range for Accumulated Depreciation.
- The sharpest annual moves came in 2021 and 2025: Accumulated Depreciation jumped 92.86% in 2021, then gained 28.97% in 2025.
- Over 5 years, Accumulated Depreciation stood at $27000.0 in 2021, then jumped by 48.15% to $40000.0 in 2022, then surged by 77.5% to $71000.0 in 2023, then jumped by 50.7% to $107000.0 in 2024, then gained by 28.97% to $138000.0 in 2025.
- According to Business Quant data, Accumulated Depreciation over the past three periods registered $138000.0, $107000.0, and $71000.0 for Q2 2025, Q2 2024, and Q2 2023 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Rezolute | 477.02 Mn | 477.02 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | 138,000.00 |
| Jun 30, 2024 | 107,000.00 |
| Jun 30, 2023 | 71,000.00 |
| Jun 30, 2022 | 40,000.00 |
| Jun 30, 2021 | 27,000.00 |
| Jun 30, 2020 | 14,000.00 |
| Jun 30, 2019 | 3,000.00 |
| Jun 30, 2018 | 518,000.00 |